Bharat Biotech International Limited

Related records

Trials (25)

• A Phase III Clinical Trial to Evaluate the Protective Efficacy of Three Doses of Oral Rotavirus Vaccine (ORV) 116E
• A Phase III Randomized, Modified Double-blind, Multi-centric, Comparative Study, to Evaluate the Non-inferiority of Immunogenicity and Safety of Hillchol® (BBV131)to Shanchol™ Along With Lot-to-lot Consistency of Hillchol®(BBV131).
• A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age.
• A Trial Using Double-Bolus THR-100 Versus Streptokinase
• An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers
• BBV152/BBV154 Heterologus Prime-Boost Study
• Clinical Trial to Evaluate the Immunogenicity of Chikungunya Vaccine
• COVAXIN in a Pediatric Cohort
• Dose Escalation Study to Evaluate Oral Rotavirus Vaccine 116E Live Attenuated in Healthy Infants 8 to 20 Weeks Old
• Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac in Healthy Infants in Vietnam
• Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac® in Healthy Infants Aged Between 6-8 Weeks in Vietnam
• Phase 3 Study to Evaluate Immunogenicity and Safety of BBV154 Booster Dose
• Phase III Study of BBV154 Intranasal Vaccine in Healthy Volunteers
• Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine MTBVAC in Healthy Indian Adults and Adolescents (BBV169/2024)
• Safety and Immunogenicity of an Intranasal SARS-CoV-2 Vaccine (BBV154) for COVID-19
• Safety and Immunogenicity of BBV121
• Safety Study of Rabies Vaccine INDIRAB® Five Doses (0.5ml) Post Exposure Administered Intramuscularly
• Study of BBIL's ROTAVAC® and ROTAVAC 5CM Vaccines in Zambia
• The Efficacy of Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants
• The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E